Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$3.56 - $6.04 $164,404 - $278,933
-46,181 Reduced 93.29%
3,320 $17,000
Q3 2023

Oct 27, 2023

BUY
$3.91 - $5.9 $146,202 - $220,612
37,392 Added 308.8%
49,501 $241,000
Q2 2023

Aug 08, 2023

BUY
$4.42 - $8.55 $25,415 - $49,162
5,750 Added 90.42%
12,109 $70,000
Q1 2023

May 15, 2023

BUY
$3.79 - $4.87 $24,100 - $30,968
6,359 New
6,359 $26,000

Others Institutions Holding RVPH

About REVIVA PHARMACEUTICALS HOLDINGS, INC.


  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $26M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.